Markets
MarketMind AI
Baskets
Alerts
F&O
MF
Reports
Screeners
Subscribe
Superstars
Portfolio
Watchlist
Insider Trades
Results
Data Downloader
Events Calendar
What's New
Explore
FAQs
All Features
Widgets
More
Search stocks
IND
USA
IND
IND
×
Close
IND
USA
Stocks
Futures & Options
Mutual Funds
News
Fundamentals
Reports
Corporate Actions
Alerts
Shareholding
Overview
Buy Sell Zone
F&O
Financials
News
All
News
Earnings Calls
Corporate Announcements
Research Reports
Reports
Technicals
Technicals
Price History/Seasonality
Delivery
Shareholding
Shareholding
Monthly MF Holdings
Bulk Block Deals
Insider Trading & SAST
Deals
Bulk Block Deals
Insider Trading & SAST
Corporate Actions
All
Dividend
Bonus
Split
Rights
Board Meetings
Alerts
About
Glenmark Pharmaceuticals Ltd.
NSE: GLENMARK
|
BSE: 532296
|
ISIN: INE935A01035
|
Industry: Pharmaceuticals
|
Mid-range Performer
2114.1000
9.30
(
0.44
%)
NSE
Apr 07, 2026
15:31 PM
58.24% Gain from 52W Low
Volume:
387.5K
Share on Facebook
Tweet
Share on LinkedIn
Share via Whatsapp
Glenmark Pharmaceuticals Ltd.
24 Dec 2024
2114.10
0.44%
GLENMARK PHARMACEUTICALS
Accumulate:
Glenmark Pharmaceuticals Ltd.
by
Geojit BNP Paribas
Target: 1720
Target
Geojit BNP Paribas
Glenmark Pharmaceuticals Ltd. is trading
above its 200 day SMA
of 1987.4
More from Glenmark Pharmaceuticals Ltd.
Recommended
Market closes higher, buoyed by gains in metal and IT stocks
Trendlyne Marketwatch |
07 Apr 2026, 03:36PM
IPO pipeline stays active, while post-listing performance remains subdued
|
06 Apr 2026, 05:47PM
Earnings Call Transcript - Q4FY20 for Glenmark Pharmaceuticals
|
29 Jun 2020